Active Not Recruiting PHASE4 INTERVENTIONAL 2-arm NCT02123056

Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects

Sponsor: University of Calgary

Interventions Matching Placebo Metoprolol

Updated 10 times since 2017 Last updated: May 8, 2024 Started: Oct 31, 2014 Primary completion: Mar 31, 2021 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Vasovagal Syncope, this trial is ongoing. The trial is conducted by University of Calgary and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Jun 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE4
Dec 2022 — Jun 2024 [monthly]

Active Not Recruiting PHASE4
Apr 2021 — Dec 2022 [monthly]

Active Not Recruiting PHASE4

Status: Unknown Status → Active Not Recruiting

▶ Show 5 earlier versions

Jan 2021 — Apr 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Nov 2018 — Jan 2021 [monthly]

Recruiting PHASE4
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Calgary
Vanderbilt University

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada
• Winnipeg, Canada